Diagnosing hereditary cancer predisposition in men with prostate cancer
Open Access
- 22 May 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (9), 1517-1523
- https://doi.org/10.1038/s41436-020-0830-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer GenesInternational Journal of Breast Cancer, 2016
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate CancerThe New England Journal of Medicine, 2016
- DNA-Repair Defects and Olaparib in Metastatic Prostate CancerThe New England Journal of Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 MutationJournal of Clinical Oncology, 2015
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseBritish Journal of Cancer, 2014
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Aggressive DiseaseCancer Epidemiology, Biomarkers & Prevention, 2013
- Drug therapy for hereditary cancersHereditary Cancer in Clinical Practice, 2011
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008